Literature DB >> 3229898

Liposome-bound cyclosporine: retinal toxicity after intravitreal injection.

A A Alghadyan1, G A Peyman, B Khoobehi, K R Liu.   

Abstract

The retinal toxicity of intraocular liposome-bound cyclosporine was studied in albino rabbits by means of electrophysiology and histopathology. During a followup period of one month, no histopathological or electroretinographic changes were noted using concentrations of 100, 200 and 500 micrograms injected intravitreally.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3229898     DOI： 10.1007/bf00137134

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN： 0165-5701            Impact factor:   2.031


  12 in total

1.  Prolonged survival of corneal allografts in rabbits treated with cyclosporin A.

Authors:  D J Coster; W F Shepherd; T C Fook; N S Rice; B R Jones
Journal:  Lancet       Date:  1979-09-29       Impact factor: 79.321

2.  Retinal toxicity study of intravitreal cyclosporin.

Authors:  J Grisolano; G A Peyman
Journal:  Ophthalmic Surg       Date:  1986-03

3.  Temperature-dependent permeability of large unilamellar liposomes.

Authors:  R L Magin; M R Niesman
Journal:  Chem Phys Lipids       Date:  1984-03       Impact factor: 3.329

4.  Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits.

Authors:  C Tremblay; M Barza; F Szoka; M Lahav; J Baum
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

5.  Suppression of secondary herpes simplex uveitis by cyclosporine.

Authors:  J O Oh; P Minasi; G Grabner; Y Ohashi
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-04       Impact factor: 4.799

6.  A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft rejection in rabbits.

Authors:  T A Bell; D L Easty; K G McCullagh
Journal:  Br J Ophthalmol       Date:  1982-05       Impact factor: 4.638

7.  Suppression of corneal allograft rejection by cyclosporin A.

Authors:  J D Salisbury; B M Gebhardt
Journal:  Arch Ophthalmol       Date:  1981-09

8.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.

Authors:  F Szoka; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

9.  Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection.

Authors:  P A Hunter; K R Wilhelmus; N S Rice; B R Jones
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

10.  Effect of cyclosporin A on the survival of corneal grafts in rabbits.

Authors:  W F Shepherd; D J Coster; T C Fook; N S Rice; B R Jones
Journal:  Br J Ophthalmol       Date:  1980-03       Impact factor: 4.638
View more
  7 in total

Review 1.  Nanocarriers of nanotechnology in retinal diseases.

Authors:  Ali M Al-Halafi
Journal:  Saudi J Ophthalmol       Date:  2014-03-05

2.  In vivo release and retinal toxicity of cyclosporine-loaded intravitreal device.

Authors:  Felipe Piacentini Paes de Almeida; Juliana Barbosa Saliba; Jefferson Augusto Santana Ribeiro; Rubens Camargo Siqueira; Sílvia L Fialho; Armando Silva-Cunha; Rodrigo Jorge; Andre Messias
Journal:  Doc Ophthalmol       Date:  2015-11-17       Impact factor: 2.379

3.  Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.

Authors:  Y N Hui; H C Liang; Y S Cai; B Kirchhof; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

4.  Diabetic retinopathy - An update.

Authors:  Abdulrahman A Alghadyan
Journal:  Saudi J Ophthalmol       Date:  2011-01-31

Review 5.  Liposomes and nanotechnology in drug development: focus on ocular targets.

Authors:  Miki Honda; Tomohiro Asai; Naoto Oku; Yoshihiko Araki; Minoru Tanaka; Nobuyuki Ebihara
Journal:  Int J Nanomedicine       Date:  2013-02-14

6.  Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion.

Authors:  Pankaj Ranjan Karn; Hyun Do Kim; Han Kang; Bo Kyung Sun; Su-Eon Jin; Sung-Joo Hwang
Journal:  Int J Nanomedicine       Date:  2014-08-08

Review 7.  Ocular Drug, Gene and Cellular Delivery Systems and Advanced Therapy Medicinal Products.

Authors:  Türkan Eldem; Bora Eldem
Journal:  Turk J Ophthalmol       Date:  2018-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.